Prototype AI test could predict promising cancer drug combinations - European Pharmaceutical Review

An AI-based test was able to predict cancer patients’ response to drugs more accurately than genetic testing, finds proof-of-concept study.

Posted: 4 April 2022 | Hannah Balfour (European Pharmaceutical Review) | No comments yet An artificial intelligence (AI)-based test was able to predict cancer patients response to drugs more accurat… [+5407 chars]

full article...